Congratulations to Rare Diseases Clinical Research Network’s (RDCRN) member Dr. Frank Rauch for receiving the Charles Slemenda Award at the 8th International Conference on Children’s Bone Health in Würzburg, Germany in June 2017 in recognition for his monumental work in pediatric bone disease research. The award is well deserved. As a pediatrician, Dr. Rauch has been treating pediatric bone diseases, particularly osteogenesis imperfecta (OI), for over 20 years. Currently, Dr. Rauch is a pediatrician with Metabolic and Genetic Bone Disorders and the Director of Clinical Laboratories at Shriners Hospitals for Children - Montreal. Additionally, Dr. Rauch is a professor with the Department of Pediatrics at McGill University. If those appointments seem to be not enough, Dr. Rauch also serves on the OI Foundation’s medical advisory council.
Dr. Rauch is also a leading researcher in pediatric bone disease. He is one of the principal investigators with the RDCRN’s Brittle Bone Disorders Consortium. Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Science (NCATS), and the Office of Rare Diseases Research (ORDR), the Brittle Bone Disorders Consortium collaboratively conducts clinical research regarding OI. The overarching goals of the Brittle Bone Disorders Consortium is to learn more about OI and to develop and improve treatments for OI. As part of the consortium, Dr. Rauch is a principal investigator for the following research studies: Longitudinal Study of OI; Cross-linked Collagen Peptides as a Urinary Biomarker of OI Pathology; and Dental Malocclusion and Craniofacial Development in OI. The Brittle Bone Disorders Consortium also actively disseminates information to persons affected by OI; including patients and their families, healthcare providers, advocates, other researchers, and other interested parties. Congrats to you, Dr. Rauch!
More information can be found at https://www.rarediseasesnetwork.org/cms/bbd.
